Please provide your email address to receive an email when new articles are posted on . Intrauterine lidocaine significantly reduced pain during and after hysteroscopy-guided biopsy compared with ...

In a large New York healthcare system, 11.4% of intrauterine device (IUD) removals required complex procedures, with age and language barriers significantly affecting complication rates. Among ...

Epidemiologic studies indicate that inadequate intrauterine nutrition is associated with increased susceptibility to develop chronic diseases in adulthood (e.g., diabetes, hypertension, and ...

The FDA gave premarket approval to the first medical device for the treatment of women with symptomatic moderate-to-severe intrauterine adhesions, known as Asherman syndrome, maker Womed announced on ...

BEDFORD, Mass.--(BUSINESS WIRE)--Rejoni, Inc., a privately held clinical-stage company, today announced the completion of enrollment of 150 patients in the Juveena Hydrogel pivotal clinical study.

Credit: Womad. The Womed Leaf consists of a proprietary polymer that is inserted into the uterine cavity immediately after completion of a hysteroscopic adhesiolysis procedure. The device is indicated ...